For instance, there is a correlation between upregulation of SIRT2 with malignancy progression in hepatocellular carcinoma (HCC) and NSCLC.[14, 44, 45] On the contrary, there is also evidence to support that SIRT2 deficiency in mice causes tumorigenesis in mammary tumors and HCC. The gene discussed is SIRT2; the disease is breast cancer.